ABSTRACT Cutaneous and lower gastromtestinal (GI) tract mucus of rainbow trout Oncorhynchus mylclss were evaluated for inlmunological responses followvlg exposure to infectious hematopoietic necrosis w u s (IHNV) Juvenlle rainbow trout (mean weight 5 4 g) were infected w~t h IHNV (isolate 220-90) by waterborne exposure to 104 plaque formmg u n~t s (pfu) m1 ' or by a n inlection challenge of 104 pfu fish-' Cutaneous mucus and lower G1 tract washings were analyzed for vuus neutrahzing achvity (antiviral achvlty) usmg a complement-dependent neutrahzation procedure Antivual achvlty was pnrnanly detected in the G1 tract and was highest in mock mfected fish (not exposedrto w u s ) T h s activity decreased rapidly over time in fish challenged by the injection route Specific antibodes were not detected in cutaneous mucus or G1 tract washings by ELISA Virus was isolated in external and G1 tract mucus from both waterborne and injection challenged fish, and showed significantly h g h e r hters in fish challenged by the inlection route Histological exarmnation of fish exposed to IHNV showed a moderate inflammatory response in the mucosal ep~thehal layer of the skin ulth mmor focal areas of cellular necrosis in severely infected fish When the study was repeated m addltion to cutaneous mucus and G1 tract washings, serum was monitored for antibody production m juvenlle ralnbow trout (mean weight 2 4 g ) out to 28 days post-exposure (dpe) Anlviral activity was confirmed m the G1 mucus, and virus neutrahzing antibodies were detected in the serum at 21 and 28 dpe in IHNV challenged fish Anhbodies in slun and G1 mucus were not detected by ELISA Virus antigen was vlsuahzed by unrnunoh~stochemistry in the ludney spleen hver heart pancreatic tissue and smooth muscle of the stomach wall Results from these expenments reveal innate mechamsms of viral resistance w h c h may be unportant as a first line of defense against IHNV
INTRODUCTION
Characterization of specific immune components in cutaneous and intestinal mucus is incomplete in fish, but the importance of the mucosal barrier in preventing invasion by pathogens is clear. Besides acting as a physical barrier, mucus covering mucosal surfaces contains antibodies and other immune components (Hart et al. 1988 , Davidson 1991 . The purpose of this study is to clanfy mucosal immunity in rainbow trout Oncorhynchus mykiss challenged with infectious hematopoietic necrosis virus (IHNV).
IHNV is enzootic to the Pacific Northwest (United States) and causes the disease infectious hematopoietic necrosis (IHN), which affects juvenile sockeye salmon Oncorhynchus nerka, chinook salmon 0. tshawytscha and rainbow trout, causing large losses of hatchery and possibly wild stocks (Wolf 1988) . Control of IHN is achieved only through avoidance (utilizing pathogen free stocks and water sources); no vaccines or effective chemotherapeutants are available. No successful means of control during an epizootic exist, although under certain circumstances manipulation of water temperatures may be useful (Amend 1970) . The use of antiviral compounds for control of IHNV has been explored (Hasobe & Saneyoshi 1985) , and although these compounds were effective in tissue culture, they were ineffective in vivo. Experimental vaccines that provide varied levels of protection have been developed, but adaptation of vaccines for use in commercial facilities has not been accomplished (Gilmore et al. 1988 .
In mammals, the mucosal immune system accounts for approximately 70% of total antibody (Service 1994) . Antibodies localized to the mucosae are of the IgA isotype and provide a first line of defense against pathogens invading mucosal sites. Increased understanding of the mucosal immune system has made possible the development of vaccines which elicit a specific mucosal immune response (McGhee et al. 1992) . In fish, knowledge of the mucosal immune system is limited (St. Louis-Cormier et al. 1984 , Hart et al. 1988 , Davidson 1991 , Loghothetis & Austin 1994 ) and the role it plays with respect to IHNV is unknown. IHNV has been isolated from mucosal surfaces (LaPatra et al. 1989 , Yamamoto et al. 1992 , Helmick 1995a and since fish are bathed in mucus (internally and externally) the virus must cross a mucosal barrier to cause disease. It is hypothesized that mucosal immunity plays a critical role as a first line of defense against invasion by IHNV.
Over the past 2 decades the presence of a primitive mucosal immune system in fish has been investigated, and researchers have demonstrated the presence of antibodies and other non-specific immune components in fish mucus (Ingram 1980 , Lobb 1987 , Austin & McIntosh 1988 , Rombout & van den Berg 1989 , Rombout et al. 1989a , b, Jenkins et al. 1994 . St. Louis-Cormier et al. (1984) found that intrapentoneal (i.p.1 injection of sheep red blood cells induced antigenically similar antibodies in both serum and mucus of trout. Antibody titers in mucus were lower than those in serum; mucus smears contained lymphoblasts, small lymphocytes and mature plasma cells in addition to epithelial cells. Lobb (1987) immunized catfish by immersion in water containing dinitrophenylated (DNP) horse serum albumin., and anti-DNP antibody was identified in cutaneous mucus. Mucosal antibodies had the same tetrameric form as serum anti-DNP antibodies and the same molecular weight heavy and light chains. Lobb also found numerous lymphocytes within the epidermis associated primarily with the basal layer. Loghothetis & Austin (1994) identified antibodies in the serum, bile, skin and gut mucus from fish immunized with killed and live cells of Aeromonas hydrophila by injection, immersion and oral routes. The antibody titer in gut mucus increased for 10 to 12 wk after administration of antigen of A. hydrophila, particularly when the bacteria were given orally. Interestingly, there was no correlation between serum and gut mucus antibody titers. Skin mucus also contained irnmunoglobulin (Ig), which increased in titer for up to 12 wk after antigen exposure then declined and rose again after secondary antigen administration. Serum antibody responses did not parallel mucosal antibody responses, suggesting a local immune response. Nevertheless, it is currently unknown if antibodies found in the mucus of fish are derived locally, as occurs in mammals, or if they are produced systemically and transported across epithelial layers into secretions.
Although the fish intestine lacks immunological structures such as Peyer's patches, it is believed that the fish intestine is irnrnunocompetent (Hart et al. 1988) . The anterior intestine in teleosts is the site primarily involved in lipid and protein absorption, while the posterior intestine is involved with the absorption of macromolecular proteins (Vernier 1990 ). The common carp Cyprinus carpio has received the most study related to the intestinal immune system. In carp, the uptake and processing of antigens such as soluble ferritin and particulate bacteria Vibrio anguillarum have been studied (Rombout & van den Berg 1989 , Rombout et al. 1989a . Both antigens are taken up in the second segment of the gut by intestinal epithelial cells. Antigen is localized in supranuclear vacuoles in epithelia1 cells and in large intraepithelial macrophages. Binding of both antigens by mucosal associated macrophages was observed (Rombout & van den Berg 1989) . Rombout et al. (1989a) found few lymphocytes in this region that were Ig positive (B cells) and suggested that unlabeled lymphocytes may be T-like cells, which may be indicative of cell-mediated defense mechanisms.
To summarize, evidence thus far suggests that fish have the ability to mount an immune response at mucosal sites and that skin and gut mucus may provide an important first line of defense. This study examined the mucosal immune response of rainbow trout exposed to IHNV to clarify the role of mucosal immunity in IHN. The objectives of this study were to characterize the mucosal immune response in rainbow trout challenged with IHNV, and to examine mucosal surfaces for pathologic changes and virus amplification.
MATERIALS AND METHODS
Fish challenges. Two separate trials were conducted to examine the local (mucosal) immune response in rainbow trout challenged with IHNV. Fish stocks for each experiment were obtained from Clear Springs Foods Inc., Buhl, Idaho, USA, and all challenges were conducted at their research facility. Prior to challenges, fish were held in 116 l tanks at 15°C in a single pass flow-through system. In the first experiment (Expt l ) , rainbow trout (mean welght 5.4 g) were challenged with IHNV (isolate 220-90; LaPatra et al. 1991) by intraperitoneal (i.p.) injection or waterborne exposure, or were mock challenged with phosphate-buffered saline (PBS). Injected fish were anesthetized with MS-222 (Argent chemical, Redmond, WA, USA) and each inoculated with 50 p1 of PBS containing 10"laque forming units (pfu) of IHNV. Waterborne infection was accomplished by immersing fish for 1 h in 1.6 1 of aerated spring water containing 104 pfu ml-' of IHNV. Mock challenged (control) fish were treated identically to the waterborne exposure groups, but received only PBS.
In the second experiment (Expt 2), rainbow trout (mean weight 2.4 g ) were challenged with IHNV by waterborne exposure (104 pfu ml-l) or mock exposed to PBS (no fish were injected).
Experimental design. The design for each experiment is outlined and described in Table 1 . Following virus challenge in Expt 1, 11 test groups (30 fish per tank) were placed in 20 1 containers supplied with ultra-violet light treated specific-pathogen-free (SPF) spring water at 15°C in a continuous flow-through system. Replicate tanks of both waterborne and injection challenged groups and a single tank containing mock challenged fish were monitored for mortality. Three sub-sample tanks, one tank for each treatment group, were treated identically and maintained for removal of fish for histology and analysis of external and G1 mucus for neutralizing activity and antibody production. Three additional sub-sample tanks were maintained for isolation of virus from external and G1 tract mucus. All fish were removed from feed 48 h prior to challenges and remained off feed throughout the 10 d experiment. In Expt 2, 7 test groups (40 fish per tank) were placed in 20 l containers supplied with ultra-vlolet light treated specific-pathogen-free (SPF) spring water at 15°C in a continuous flow-through system following virus challenge. Repl~cate tanks of IHNV infected fish and a single tank containing mock infected fish were monitored for mortality. Two sub-sample tanks, one tank for each treatment group, were maintained for removal of fish for histology and analysis of external and G1 mucus for neutralizing activ~ty and antibody production. Two additional sub-sample tanks were maintained for isolation of virus In external a n d G1 tract mucus. Fish were taken off feed 24 h prior to challenges. During the experiment, fish were fed twice daily, but removed from feed 72 h before sampling to ensure that no food was present in the G1 tract.
Sampling. In Expt 1, 5 randomly selected fish were removed from mock challenged groups and sacrificed on Days 0, 1, 3 and 8, while IHNV challenged groups were sampled in the same manner on Days 1, 2, 3, 6, 8 and 10. Cutaneous and lower G1 tract mucus was collected from each fish. Cutaneous mucus was collected by placing individual fish in 2.0 mil (= 0.05 mm thick) clear polypropylene bags for approximately 4 to 5 min. Fish were removed, and mucus within each bag was collected in 0.5 m1 microfuge tubes. Gastrointestinal mucus was collected by removing the lower G1 tract from sacrificed fish and first expelling any remaining fecal material by light external digital pressure with blunt forceps. Intestinal mucus was then collected by inserting a 1 cc syringe, containing 200 p1 PBS a n d fitted with a 20 gauge needle, into the anterior end of the excised intestinal tract a n d flushing material into a 0.5 m1 microfuge tube. Any remaining mucus was expelled with forceps. Samples obtained from G1 tract washings were vortexed to allow thorough mixing, and then centrifuged at 1600 X g. Cutaneous and G1 tract mucus was assayed for anti-IHNV neutralizing activity using a complement-dependent 50 % plaque neutralization procedure , Ristow et al. 1993 ) and for specific antibodies using a modified ELISA (Arkoosh & Kaattari 1990 , Ristow et al. 1993 ; see below). Virus isolation was attempted from all mucus samples and from kidney-liver-spleen homogenates from a minimum of 20% daily mortalities using a plaque assay (LaPatra et al. 1989 ). Additionally, sections of dorsal skin and epaxial muscle were removed for histology and fixed in 1 0 % neutral buffered formalin (NBF). These sections were obtained by removing approximately a 2 cm2 piece of skin with underlying muscle from behind the operculum extending horizontally along the lateral Line and vertically to the base of the dorsal fin. Fixed tissues were paraffin embedded using standard procedures a n d sectioned at 5 pm.
In Expt 2, groups of fish were monitored at 1, 7, 14, 21 and 28 d post-exposure (dpe) for antiviral activity in the serum, cutaneous mucus and G1 tract mucus. Random samples of 5 fish were removed from tanks at weekly intervals. In an effort to increase ylelds of cutaneous mucus, 200 p1 of 0.85% (physiological) saline was added to each polypropylene bag prior to addition of fish (the use of PBS or 0.85% physiological saline was necessary to obtain a large enough sample size for analysis and resulted in an initial dilution of those samples). Serum samples were obtained by severing the caudal peduncle and collecting blood in 0.1 m1 hematocrit tubes. Blood from each fish in the pool was combined and allowed to clot at 4°C overnight. Serum was harvested after samples were centrifuged at 1600 X g for 5 min. Whole fish were opened ventrally and immersed in 10 % NBF. Cutaneous and G1 mucus were examined for the presence of virus, specific antibody and IHNV neutralizing activity (see methods below). Virus isolation and neutralizing activity assays were conducted within 24 h of sample collection in both experiments, while samples to be assayed by ELISA were stored at -70°C until analyses could be performed.
Enzyme linked immunoassay (ELISA). An ELISA to detect the presence of antibody against IHNV in the mucus of rainbow trout was developed. The ELISA was modeled after other methods described for antibody detection (Arkoosh & Kaattari 1990 , Ristow et al. 1993 . Briefly, 96-well Immulon I microtiter plates were coated with 0.05 pg of purified IHNV per well (isolate 220-90) in bicarbonate coating buffer (0.7 95 g NaC03 and 1.465 g NaHC03 in 500 ml double distilled water adjusted to pH 9.6) overnight at 4°C. Wells were blocked with 3% bovine serum albumin (BSA) in phosphate-buffered saline containing 0.05 % Tween 20 (PBST-BSA 3 %) for 2 h at room temperature. Replicate samples of mucus were diluted (1:4, 1:8, 1:16 and 1:32) in PBST-BSA 3% and incubated for 24 h at 16°C. A biotinylated mouse anti-trout immunoglobulin (DeLuca et al. 1983 ) was applied and incubated for 1 h at 37°C. A 1:3000 dilution of streptavidin-peroxidase (Zyrned, San Francisco, CA, USA) in PBST-BSA 1 % was applied for 1 h at 37°C. Finally, 0.1 % 5-amino salicylic acid containing 0.005 % hydrogen peroxide was added and allowed to react in the dark for 1 h. Plates were read at 490 nrn using a Cambridge plate reader spectrophotometer. Anti-IHNV titers were considered positive if the reciprocal of the highest dilution was twice the background control (negative serum) optical density value (Voller et al. 1979) . Wells were rinsed between steps with PBST.
Complement-dependent neutralization. Virus neutralizing activity in slun and G1 mucus and serum of rainbow trout was analyzed using a complementdependent, 50 % plaque neutralization assay , Ristow et al. 1993 ). Samples were heatinactivated (45°C for 30 min) to destroy residual complement, and 2-fold dilutions of mucus (1:4 to 1:32) and serum (1:20 to 1:160) were made in 50 p1 Hanks' balanced salt solution in 96-well round bottom tissue culture plates (Corning Glassworks, Corning, NY, USA). An equal volume of diluted virus (IHNV isolate 220-90) was added to each well, and plates were incubated for 30 rnin on a rocker platform at 18°C. Complement (1:lO dilution) was added to each well and plates incubated an additional 30 r n i n at 18°C.
Complement was obtained from SPF trout (Clear Springs stock) that remained off feed for at least 2 wk. Samples were inoculated in duplicate onto polyethylene glycol (PEG) pretreated monolayers of Epithelioma papulosum cyprini (EPC) cells (Fijan et al. 1983 ) grown in 48-well plates and plates were incubated for 1 h on a rocker platform at 18OC to allow for viral adsorption. The inoculum was removed, monolayers overlaid with methyl-cellulose based media (Sigma Chemical, St. Louis, MO, USA), and plates were incubated at 18°C for 6 d. Cells were fixed and stained with crystal violetlformalin and neutralization titers were determined by taking the reciprocal of the dilution resulting in a 50 % reduction in plaques compared to negative controls. Positive and negative serum samples were used as controls in all tests.
Virus assay. Skin and G1 mucus, along with kidneyLiver-spleen homogenates from a minimum of 20% of the daily mortalities from each tank, were assayed for virus. Quantification of virus isolated from mucus samples or mortalities was accomplished using a plaque assay procedure previously described (LaPatra et al. 1989) .
Histology. Histological samples were embedded in paraffin blocks by routine methods and 5 pm sections were cut and mounted. Sections were stained in hematoxylin/eosin and examined using light microscopy.
Immunohistochemistry. Samples processed for immunohistochemistry were sectioned as described and mounted on charged precleaned microscope slides (ProbeOnTM Plus, Fisher Scientific, Pittsburgh, PA. USA) used with a MicroProbeTM manual stainer. An a l k a h e phosphatase irnrnunohistochernical procedure modified from Drolet et al. (1993 Drolet et al. ( , 1994 was utihzed for visualization of viral antigen using light microscopy. Sections were deparaffinized in Propar (Anatech, Battle Creek, MI, USA) and rehydrated by immersing slides for approximately 10 s in graded ethanol (95 to 70%) to distilled water. To unmask protein antigens crosslinked by prolonged formalin fixation, an antigen retrieval solution (Biogenix, San Ramon, CA) was used. Briefly, deparaffinized slides were immersed in the antigen retrieval solution and the solution was brought to a rapid boil in a microwave oven for 3 min. Power was reduced to 50 %, and slides were boiled for an additional 7 min. Slides were allowed to cool 20 min and blocked with 5'2: non-fat dried milk in PBS for l h. After blotting, monoclonal antibody (3GH136.l) to the G glycoprotein of IHNV (Ristow & Arnzen d e Avila 1991) diluted 1:1000 was applied, and slides were incubated for 1 h at room temperature. Slides were washed 10 times with PBS, and a biotinylated goat anti-mouse IgG (Dako Corporation, Carpinteria, CA) secondary antibody was applied for 30 rnin at room temperature. After washing, ABC-APase (Vector Laboratories, Burlingame, CA) was applied for 30 min, then the substrate (Vector Red, Vector Laboratories, Burlingame, CA) was applied, and color development was allowed to proceed for 10 to 15 min at room temperature. The reaction was stopped by rinsing for 5 min in distilled water. Tissues were then counterstained in hematoxylin for 2 min followed by a tap water rinse for 5 min. Slides were dehydrated by immersing for approximately 10 s in distilled water, 70, 85 and 95% ethanol and coverslipped using Permount mounting media (Fisher Scientific).
Prior to imrnunostaining of samples, extensive preliminary testing to achieve optimal identification of viral antigen was conducted. This involved utilizing tissues known to be infected with IHNV and negative tissues. A number of primary monoclonal antibodies to IHNV (Ristow & Arnzen de Avila 1991) were tested for their ability to detect antigen with minimal background staining. Once appropriate dilutions of primary and secondary antibody were determined, control sections were processed to detect non-specific reagent binding. Controls included tissues known to contain IHNV, tissues free of IHNV, blocking solution substituted for the primary antibody, blocker substituted for both primary and secondary antibodies, and negative Ig isotype control substituted for primary antibody. By this procedure, any antibody or reagent producing background reaction was identified. Known negative tissues (from mock challenged fish) were always run with tissues obtained from IHNV challenged fish.
Statistical analysis. Virus and neutralization titers were analyzed using a l-way analysis of variance (ANOVA). Differences in cumulative mortality between infected and uninfected treatment groups were determined by chi-square analysis. Since some values were missing due to mortalities in infected groups of fish, data were analyzed using split-plot analysis. Values were considered significantly different at p values < 0.05.
RESULTS

Cumulative mortality and viral isolation
In Expt 1, fish infected with IHNV by injection exhibited a cumulative mortality of 87 % (52/60) with daily mortality reaching a maximum at 6 dpe (Table 2) . Mortality in the waterborne exposed group reached a maximum at 5 dpe with a cumulative mortality of 27 % (16/60). There was a significant difference (p < 0.05) in cumulative mortality between fish infected by the 2 methods. In Expt 2, waterborne challenged fish had a cumulative mortality of 59% (47/80), and daily mortality reached a maximum at 8 dpe (Table 2) . Mortality was not observed in mock exposed fish in either experiment.
In Expt 1, mucus collected from the skin and G1 tract of fish challenged with IHNV by injection or waterborne exposure contained virus at concentrations ranging from 1.7 X 10' to 2.0 X 107 pfu ml-'. Virus titers in skin and G1 tract mucus were significantly higher (p < 0.05) for fish exposed to IHNV by the injection route compared to waterborne exposure (Fig. 1) . The number of fish testing positive for virus in skin and G1 mucus reached a maximum at 3 dpe in both treatment groups (data not shown).
In Expt 2, virus was only isolated from the G1 tract of infected fish at 7 dpe, while samples of external mucus tested positive at 1, 7 and 14 dpe; however, only 1 of 5 fish had a positive titer at Day 14 (data not shown). No virus was detected in either skin or G1 mucus beyond 14 dpe, and virus was not isolated from mock challenged fish in either experiment.
Antiviral activity in cutaneous and gastrointestinal mucus
In Expt 1, antiviral activity was detected in the skin mucus from a small number (8/82) of fish but at rela- Table 2 . Oncorhynchus myluss. Cumulative percent mortality of juverule rainbow trout challenged with infectious hematopoietic necrosis virus (IHNV). Fish in Expt 1 were either waterborne exposed to 104 pfu ml-l IHNV, injected with 104 pfu fish-' or mock exposed and monitored for 10 d, while fish in Expt 2 were waterborne exposed to 104 pfu ml-' IHNV or mock exposed and monitored for 28 dpe. nd: not done Histological examination of dorsal skin and muscle sections of fish in the first experiment identified subtle pathological changes associated with IHNV infection. A moderate inflammatory response (infiltration of lymphocytes) was observed in the epidermal region of the skin at 3 dpe and was detected out to 10 dpe. Small, rare areas of epithelial cell necrosis within the skin was observed in pfu ml-') in skin and lower G1 tract mucus of fish challenqed with IHNV skin ( Fig. 2A) Table 3) . Gastrointestinal mucus from mock exposed fish showed the highest average titer at 11.4, while G1 mucus from waterborne exposed fish had an average titer of 6.4. Fish which were injected with virus had the lowest the average titer (1.27). In Expt 2, IHNV neutralizing activity was not detected in cutaneous mucus collected from mock exposed fish, and detected in infected fish only at 1 dpe (data not shown). Comparison of antiviral activity in the G1 mucus of infected and uninfected fish showed no significance difference when averaged over the entire 28 d ; however, a time-wise comparison revealed statistical significance (p < 0.05) only a t 7 dpe, when virus involvement was most severe (Table 4) .
Anti-IHNV antibody production in cutaneous mucus,
G1 mucus and serum
No anti-IHNV antibodies were detected by ELISA in the cutaneous and G1 mucus of infected or uninfected fish tested out to 28 dpe. Fish surviving IHNV challenge, however, showed anti-IHNV neutralizing antibodies in pooled serum samples at 21 and 28 dpe (Table 5) . Antibodies were not detected in unchallenged fish. Table 3 . Oncorhynchus mykiss. Anti-IHNV neutralizing activity in G1 mucus samples collected from samples (5 fish per sample) in infected and uninfected treatment groups out to 10 dpe. Titers were determined by complement dependent neutralization and are given as the reciprocal of the highest dilution which resulted in a 50% reduction in viral plaques. Titers recorded as less than the lowest dilution tested (e.g. <4) were treated as zero for analysis, whlle titers recorded as greater than or equal to the highest dilution tested (e.g. 232) were treated as the given value. Blanks (-) Table 4 . Oncorhynchus mykiss. Anti-IHNV neutralizing activity in G1 mucus collected from samples (5 fish per sample) from infected and uninfected treatment groups in Expt 2. A cornplement-dependent neutralization assay was used, and t~ters are given as the reciprocal of the hlghest dilution which resulted in a 50% reduction in viral plaques. Titers recorded as less than the lowest dilution tested (e.g. <4) were treated as zero for analysis, while titers recorded as greater than or equal to the highest dilution tested (e.g. 232) were treated as the given value. A significant treatment dlffesence (p < 0.05) was present at 7 d post-exposure. Blanks (-) represent missing samples (due to mortalities) Sample Days post-exposure no. signs associated with severe infection. Cell necrosis was extensive in the anterior kidney, spleen, peripancreatic tissue, liver, heart and gastric smooth muscle, and viral antigen was visualized by immunohistochemical staining (Fig. 3) . In the kidney and spleen, there was extensive necrosis and fragmentation of hematopoietic cells. In severely infected fish, focal areas of necrosis were observed in the liver and gastric smooth muscle; and myocytes within the stomach wall were fragmented, hyalinized, swollen and had n'uclear pyknosis. Viral antigen localized to endothelial cells of blood vessels and adjacent interstitium in the stomach and pancreatic tissue. Viral antigen and associated necrosis of pancreatic acinar cells was observed, but less frequently than antigen localization to interstitial vasculature. 
DISCUSSION
In this study, IHNV was isolated from the skin and G1 mucus of rainbow trout following virus challenge. The number of fish testing positive for virus in the skin and G1 mucus in Expt 1 was found to increase and reach a maximum at 3 dpe. LaPatra et al. (1989) demonstrated similar patterns of virus infection in external mucus, and it has been shown that virus replication in excised epidermal tissues slows between 3 and 4 dpe (Yamamoto et al. 1992) . In Expt 2, virus was not isolated beyond 14 dpe from either the skin or G1 mucus. This suggests that the virus may have been cleared from these areas and viral replication was not occurring at these later times. Yamamoto et al. (1990 Yamamoto et al. ( , 1992 used immunohistochemistry and plaque assay to observe and quantify virus antigen in the skin of waterborne exposed fish and In excised epidermal tissues of rainbow trout. They suggested that the skin may be a portal of entry and viral replication may aid in horizontal transmission. This study confirms early presence of virus in the skin mucus, but histological observations showed little associated pathology unless fish were undergoing severe systemic infection. Irnmunohistochemical staining revealed only minor virus involvement in areas of cellular necrosis within the basal lamina of the skin. These regions did not appear to be major sites of virus replication. Intense staining and associated pathological changes were consistently observed in the internal organs of infected fish. Viral antigen wds not observed at the skin surface. Differences from previous reports may be due in part to differences in location of sample excision (dorsal-lateral rather than ventral-abdominal), challenge dose, or sensitivity of staining using antigen retrieval procedures. Recent studies have identified the esophagus/cardiac stomach region as a site of early viral pathogenesis, and it appears this may play a greater role as a possible portal of entry for the virus than infection and entry through the skin (Helmick 1995a, b) .
What is obvious from this study is that if virus replication within the epithelial cells at the surface of the skin is occurring, minimal pathology is associated. It may be possible that an increase in virus concentration on the skin is due to adherence rather than large scale replication within the epithelial cells. If surface epithelial cells are producing virus, then mechanisms must exist which eliminate infection prior to cell destruction in fish surviving an epiz,ootic. In severely infected fish, destruction of epithelial cells adjacent to dermal blood vessels was observed, and it is possible that this could serve to transport virus to the surface of the fish and therefore act as a means of horizontal transmission prior to death of the animal.
Fish surviving an IHN epizootic are known to elicit a systemic immune response confirmed by the presence of neutralizing antibody titers in the serum , Ristotv et al. 1993 ), but not all surviving fish have detectable levels of antibody to IHNV (Ristow et al. 1993) . Mortality from IHN reaches a maximum approximately 1 wk after virus exposure, but anti-IHNV antibodies are generally not detected until some time later. These observations suggest that other mechanisms, which act early in the infection, exlst and are important in resistance to IHNV. In this study, mucosal sites as well as serum samples were evaluated. Antibody production was observed at 21 and 28 dpe in pooled serum samples from juvenile rainbow trout (mean weight 2.4 g) confirming their ability to mount a humoral immune response to IHNV. Antibody production in the mucus (skin and G1 tract) in response to stimulation with virulent virus was not observed. However, antiviral activity was observed in the mucus. It is possible that this activity could serve as an early defense mechanism against IHNV and may be due to an innate potentially non-lymphoid substance. Yamamoto et al. (1992) saw no differences in the ability to infect excised epithelial tissues from fish surviving a previous exposure to IHNV compared to fish never infected with the virus, and suggested that long term established immunity in the skin may be minimal in response to IHNV. The present study supports this, and suggests that mucosal antibodies are not involved in preventing infection or clearing virus from these sites. However, it should be noted that Ig isotypes or Ig molecules incapable of binding to the anti-trout antibody used in the ELISA would not be detected. Antiviral activity, measured by the ability to neutralize IHNV, was detected in the mucus of rainbow trout. Neutralizing titers were greatest in the G1 tract of uninfected fish and therefore were non-antibody mediated. In fish challenged by injection, this activity was detected in the G1 mucus at 1 dpe but was minimal thereafter, suggesting an inhibition of antiviral activity due to increased virus replication had occurred. Fish undergoing a more natural infection (waterborne exposure) had detectable antiviral titers for a much longer period of time, but at significantly lower levels than uninfected fish. Severe infection (injection challenge) rapidly eliminated the amount of antiviral activity that was detected. Expt 2 confirmed the presence of IHNV neutralizing activity in these secretions, and again, intestinal mucus had a greater level of antiviral activity than cutaneous mucus. The low levels of antiviral activity detected in the skin mucus may be related to the dilute nature of the samples obtained from these juvenile fish, but the mere fact of its detection suggests that the external mucus may serve as more than just a physical barrier.
Non-lymphoid antibacterial compounds have been identified in fish mucus and may be associated with the presence of certain protein or carbohydrate moieties (Ingram 1980) . Austin & McIntosh (1988) found that bacterial growth was inhibited in the presence of skin and eye secretions from rainbow trout. Other researchers have found that mucus from uninfected rainbow trout exhibited anti-Vibrio anguillarum activi.ty and suggested that external and gut mucus may represent a first line of defense due to the presence of antimicrobial activity (Harrell et al. 1976 ). Lysozyrne (Fletcher & Grant 1968 , Fletcher & White 1973 and natural agglutinins and lysins (Spitzer et al. 1976 ) are also present in the skin mucus of fish. Furthermore, the ability of fish to alter the amount of mucus secreted in response to stressors is thought to influence the level of initial resista.nce to invasion by microorganisms (Pickering 1976 , Pickel-ing & Macey 1977 .
Early on, it was suggested that development of effective viral vaccines for fish would only be accomplished when a greater understanding of the immune system of fish was achieved (Amend & Smith 1975) Since then, much has been learned about the immune response to IHNV, but as yet no efficacious marketable vaccines exist. The need for further characterization of the total immune response to IHNV is therefore apparent. This study has focused on mucosal sites in rainbow trout which act a s barriers which must b e penetrated for internal viral infection to occur. In a n evaluation of the immunity at these sites in response to IHNV, it was discovered that innate anti-viral factors exist in G1 mucus and to a lesser extent in cutaneous mucus of skin. Detection of antiviral activity was significantly higher in uninfected fish (not exposed to virus) and was not stimulated by exposure to IHNV. This paper is the first report that rainbow trout possess a n innate, possibly non-lymphoid, mechanism of protection that may be important as a first line of defense against IHNV.
